Suppr超能文献

体外对AKR白血病有反应的同种免疫诱导T淋巴细胞的特征及与体内移植物抗白血病活性的相关性

Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.

作者信息

Truitt R L, Shih C Y, Lefever A V, Tempelis L D, Andreani M, Bortin M M

出版信息

J Immunol. 1983 Oct;131(4):2050-8.

PMID:6194224
Abstract

We have reported that immunization of H-2k mice with lymphoid cells from various allogeneic strains induced a population of cells that could eliminate first-passage spontaneous AKR leukemia from the spleens of immuno-suppressed AKR (H-2k) hosts. In the present study, we examined the nature of the cells responsible for this graft-vs-leukemia (GVL) reaction and compared them to cytolytic cells detected in vitro. Spleen cells from alloimmunized CBA/J (H-2k) mice were selectively depleted of various subpopulations by treatment with antibody and complement (C), then tested in vivo for GVL reactivity. Cell suspensions depleted of Thy-1.2+, Lyt-1+, or Lyt-2+ lymphocytes had no significant GVL reactivity, whereas suspensions depleted of NK-1.2+ cells retained GVL reactivity. The GVL-reactive cells persisted in H-2-compatible donor mice for up to 56 days. Lyt-1+2+ lymphocytes that were cytotoxic for cultured AKR leukemia cells in vitro could be detected in the spleens of alloimmunized H-2-compatible mice after expansion of the cells in T cell growth factor. Using quantitative limiting dilution cytotoxicity assays, we found that the frequency of leukemia-reactive cytotoxic lymphocytes (CL) in the spleen showed a direct correlation with the GVL efficacy of the cells in vivo. Alloimmunization was essential for induction of the GVL-reactive cell population. CL in alloimmunized mice consisted of heterogeneous cytotoxic specificities; i.e., some CL were leukemia-specific, others lysed only nonleukemic AKR target cells, and a third group mediated killing of both leukemic and nonleukemic target cells. The CL appeared to be H-2 restricted and specific for non-H-2 antigens shared by the AKR leukemia and the alloimmunizing cells.

摘要

我们曾报道,用来自各种同种异体品系的淋巴细胞免疫H-2k小鼠,可诱导出一群细胞,该群细胞能够清除免疫抑制的AKR(H-2k)宿主脾脏中的初代自发AKR白血病细胞。在本研究中,我们检测了负责这种移植物抗白血病(GVL)反应的细胞的性质,并将它们与体外检测到的溶细胞性细胞进行了比较。通过用抗体和补体(C)处理,选择性去除同种免疫的CBA/J(H-2k)小鼠的脾细胞中的各种亚群,然后在体内测试其GVL反应性。去除Thy-1.2+、Lyt-1+或Lyt-2+淋巴细胞的细胞悬液没有明显的GVL反应性,而去除NK-1.2+细胞的悬液仍保留GVL反应性。GVL反应性细胞在H-2相容的供体小鼠中持续存在长达56天。在T细胞生长因子中扩增细胞后,在同种免疫的H-2相容小鼠的脾脏中可检测到体外对培养的AKR白血病细胞具有细胞毒性的Lyt-1+2+淋巴细胞。使用定量极限稀释细胞毒性试验,我们发现脾脏中白血病反应性细胞毒性淋巴细胞(CL)的频率与细胞在体内的GVL效力呈直接相关。同种免疫对于诱导GVL反应性细胞群体至关重要。同种免疫小鼠中的CL由异质的细胞毒性特异性组成;即,一些CL是白血病特异性的,其他的仅裂解非白血病AKR靶细胞,第三组介导白血病和非白血病靶细胞的杀伤。CL似乎受H-2限制,并且对AKR白血病和同种免疫细胞共有的非H-2抗原具有特异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验